Key Success Factors in Conducting a Translational Clinical Study

Webinar - On Demand

Key Success Factors in Conducting a Translational Clinical Study

Date: January 19, 2023

Duration: 1 hour

Precision and biomarker-driven clinical studies are increasingly common, presenting challenges in sample collection, management, and analysis. Effective planning and management of the sample lifecycle are crucial for both clinical operations and translational research, as analyses impact study decisions, submissions, and future planning.

This webinar features experts who will share strategies to tackle logistical challenges and integrate clinical operations with translational research, including two case studies highlighting innovative sample collection and management approaches for consistent, high-quality data.

Register to Watch Webinar

Topics covered

For clinical operations, biomarker operations, clinical trial managers, and others involved in managing trials or samples:

Significance of biomarkers and biomarker assays in precision medicine trials
Effective planning around primary, secondary, and exploratory endpoints
Overcoming operational challenges of clinical sample collection and related data management

For translational and biomarker researchers or other scientists:

How assay needs and trial design impact sample collection and logistics
Effective ways to work with clinical operations to ensure the best quality samples for your biomarker and other assays

Speakers

Joseph Neal

Senior leader with expertise in leading teams through top-line programs and highly technical issues in the biopharmaceutical industry. Experienced in supply chain strategy and leadership, manufacturing operations and support, new facility design and start-up, tech transfer, and R&D process development.

(SizeLimitingPyList: [linkedin])
Deb Phippard, PhD

Chief Scientific Officer at Precision for Medicine. Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.

(SizeLimitingPyList: [linkedin])